Similar Papers

Paper Title
Journal
Date
Author
Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
M Tada ... H Nakamura
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | VOL. 27
M Tada, et. al.M Tada ... H Nakamura
21 Aug 2015
Clinical Implications of Bone Metabolic Markers in Patients with Type 2 Diabetes Mellitus
Yujie Wu
INTERNATIONAL JOURNAL OF HUMAN GENETICS | VOL. 22
Yujie WuYujie Wu
15 Feb 2022
Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.
Shoichiro Nagasaka ... Genro Fujisawa
Clinical endocrinology | VOL. 47
Shoichiro Nagasaka, et. al.Shoichiro Nagasaka ... Genro Fujisawa
01 Aug 1997
Relationship between serum level of miR-338-3p and miR-105-3p and bone metabolic markers in patients with diabetes nephropathy
Jinlan Liu ... Lixing Dai
Renal Failure | VOL. 46
Jinlan Liu, et. al.Jinlan Liu ... Lixing Dai
08 Oct 2024
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin.
Alyxzandria M Gaydosik ... Patrizia Fuschiotti
Annals of the rheumatic diseases | VOL. -
Alyxzandria M Gaydosik, et. al.Alyxzandria M Gaydosik ... Patrizia Fuschiotti
01 Feb 2025
Lipidomics unravels lipid changes in osteoarthritis articular cartilage.
Qiongfei Zhou ... Rik J Lories
Annals of the rheumatic diseases | VOL. -
Qiongfei Zhou, et. al.Qiongfei Zhou ... Rik J Lories
01 Feb 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.
Qingran Yan ... Oliver Distler
Annals of the rheumatic diseases | VOL. -
Qingran Yan, et. al.Qingran Yan ... Oliver Distler
01 Feb 2025
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls.
Zahi Touma ... Miina Waratani
Annals of the rheumatic diseases | VOL. -
Zahi Touma, et. al.Zahi Touma ... Miina Waratani
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.